questionsmedicales.fr
Thérapeutique
Hyperthermie provoquée
Hyperthermie provoquée : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hyperthermie
Diagnostic médical
Tests diagnostiques
Hyperthermie
Hyperthermie
Surveillance médicale
Symptômes
5
Troubles de la conscience
Hyperthermie
Éruption cutanée
Hyperthermie
Prévention
5
Surveillance
Hyperthermie
Alimentation
Hyperthermie
Traitements
5
Consultation médicale
Hyperthermie
Complications
5
Complications
Hyperthermie
Facteurs de risque
5
Facteurs de risque
Hyperthermie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperthermie provoquée : Questions médicales les plus fréquentes",
"headline": "Hyperthermie provoquée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperthermie provoquée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-20",
"dateModified": "2025-03-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperthermie provoquée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapeutique",
"url": "https://questionsmedicales.fr/mesh/D013812",
"about": {
"@type": "MedicalCondition",
"name": "Thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013812",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Psammothérapie",
"alternateName": "Ammotherapy",
"url": "https://questionsmedicales.fr/mesh/D000646",
"about": {
"@type": "MedicalCondition",
"name": "Psammothérapie",
"code": {
"@type": "MedicalCode",
"code": "D000646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.020"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diathermie",
"alternateName": "Diathermy",
"url": "https://questionsmedicales.fr/mesh/D003972",
"about": {
"@type": "MedicalCondition",
"name": "Diathermie",
"code": {
"@type": "MedicalCode",
"code": "D003972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.280"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ultrasonothérapie",
"alternateName": "Ultrasonic Therapy",
"url": "https://questionsmedicales.fr/mesh/D014464",
"about": {
"@type": "MedicalCondition",
"name": "Ultrasonothérapie",
"code": {
"@type": "MedicalCode",
"code": "D014464",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.280.945"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chimiothérapie hyperthermique intrapéritonéale",
"alternateName": "Hyperthermic Intraperitoneal Chemotherapy",
"url": "https://questionsmedicales.fr/mesh/D000084262",
"about": {
"@type": "MedicalCondition",
"name": "Chimiothérapie hyperthermique intrapéritonéale",
"code": {
"@type": "MedicalCode",
"code": "D000084262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.370"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bain de vapeur",
"alternateName": "Steam Bath",
"url": "https://questionsmedicales.fr/mesh/D029002",
"about": {
"@type": "MedicalCondition",
"name": "Bain de vapeur",
"code": {
"@type": "MedicalCode",
"code": "D029002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.640"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hyperthermie provoquée",
"alternateName": "Hyperthermia, Induced",
"code": {
"@type": "MedicalCode",
"code": "D006979",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mohammad-Amin Abdollahifar",
"url": "https://questionsmedicales.fr/author/Mohammad-Amin%20Abdollahifar",
"affiliation": {
"@type": "Organization",
"name": "Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: abdollahima@sbmu.ac.ir."
}
},
{
"@type": "Person",
"name": "Abbas Aliaghaei",
"url": "https://questionsmedicales.fr/author/Abbas%20Aliaghaei",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Jon E Sprague",
"url": "https://questionsmedicales.fr/author/Jon%20E%20Sprague",
"affiliation": {
"@type": "Organization",
"name": "The Ohio Attorney General's Center for the Future of Forensic Science, USA. Electronic address: jesprag@bgsu.edu."
}
},
{
"@type": "Person",
"name": "Amir Raoofi",
"url": "https://questionsmedicales.fr/author/Amir%20Raoofi",
"affiliation": {
"@type": "Organization",
"name": "Leishmaniasis Research Center, Department of Anatomy, Sabzevar University of Medical Sciences, Sabzevar, Iran."
}
},
{
"@type": "Person",
"name": "Shabnam Abdi",
"url": "https://questionsmedicales.fr/author/Shabnam%20Abdi",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomical Sciences & Cognitive Neuroscience, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system.",
"datePublished": "2023-04-03",
"url": "https://questionsmedicales.fr/article/37019248",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neubiorev.2023.105155"
}
},
{
"@type": "ScholarlyArticle",
"name": "Real-World Outcomes of Proprotein Convertase Subtilisin Kexin-9 Inhibitor Use.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/36795508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/FJC.0000000000001404"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of serum proprotein convertase subtilisin/kexin type 9 in pediatric sepsis syndrome.",
"datePublished": "2024-07-07",
"url": "https://questionsmedicales.fr/article/38972879",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-65609-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35508401",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/heartjnl-2021-320556"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between proprotein convertase subtilisin/kexin type 9 and subclinical cerebrovascular disease in the community.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36727585",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ene.15723"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hyperthermie provoquée",
"item": "https://questionsmedicales.fr/mesh/D006979"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperthermie provoquée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperthermie provoquée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperthermie provoquée",
"description": "Comment diagnostiquer l'hyperthermie provoquée ?\nQuels tests sont utilisés pour confirmer l'hyperthermie ?\nQuels signes cliniques indiquent une hyperthermie ?\nL'hyperthermie est-elle toujours dangereuse ?\nComment différencier l'hyperthermie de la fièvre ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Proprotein+Convertase+9#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperthermie provoquée",
"description": "Quels sont les symptômes de l'hyperthermie provoquée ?\nL'hyperthermie provoquée cause-t-elle des douleurs ?\nPeut-on avoir des troubles de la conscience ?\nY a-t-il des signes cutanés associés ?\nL'hyperthermie provoquée affecte-t-elle la respiration ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Proprotein+Convertase+9#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperthermie provoquée",
"description": "Comment prévenir l'hyperthermie provoquée ?\nLes vêtements influencent-ils l'hyperthermie ?\nFaut-il surveiller la température corporelle ?\nLes pauses sont-elles importantes ?\nL'alimentation joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Proprotein+Convertase+9#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperthermie provoquée",
"description": "Comment traiter l'hyperthermie provoquée ?\nDes médicaments sont-ils nécessaires ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il consulter un médecin ?\nLe repos est-il recommandé ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Proprotein+Convertase+9#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperthermie provoquée",
"description": "Quelles complications peuvent survenir ?\nL'hyperthermie peut-elle être mortelle ?\nQuels organes sont les plus affectés ?\nDes séquelles peuvent-elles persister ?\nComment éviter les complications graves ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Proprotein+Convertase+9#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperthermie provoquée",
"description": "Qui est le plus à risque d'hyperthermie ?\nL'exercice augmente-t-il le risque ?\nLes médicaments influencent-ils le risque ?\nL'humidité joue-t-elle un rôle ?\nLe surpoids est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Proprotein+Convertase+9#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperthermie provoquée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique et la mesure de la température corporelle."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer l'hyperthermie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des évaluations physiologiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une hyperthermie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une température élevée, des frissons et une confusion mentale."
}
},
{
"@type": "Question",
"name": "L'hyperthermie est-elle toujours dangereuse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, elle peut être contrôlée, mais nécessite une surveillance."
}
},
{
"@type": "Question",
"name": "Comment différencier l'hyperthermie de la fièvre ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperthermie est causée par des facteurs externes, alors que la fièvre est une réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hyperthermie provoquée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges, des maux de tête et une confusion."
}
},
{
"@type": "Question",
"name": "L'hyperthermie provoquée cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des douleurs musculaires et des crampes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des troubles de la conscience ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la conscience peuvent survenir en cas d'hyperthermie sévère."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rougeurs ou des éruptions cutanées peuvent apparaître en cas d'hyperthermie."
}
},
{
"@type": "Question",
"name": "L'hyperthermie provoquée affecte-t-elle la respiration ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner une respiration rapide et superficielle."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperthermie provoquée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les environnements chauds et hydratez-vous régulièrement lors d'activités physiques."
}
},
{
"@type": "Question",
"name": "Les vêtements influencent-ils l'hyperthermie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter des vêtements légers et respirants aide à prévenir l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller la température corporelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surveiller la température est essentiel lors d'activités à risque."
}
},
{
"@type": "Question",
"name": "Les pauses sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, prendre des pauses régulières lors d'activités physiques intenses est crucial."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée aide à maintenir une bonne régulation thermique."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hyperthermie provoquée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut le refroidissement du corps et l'hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être administrés pour soulager les symptômes associés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'hydratation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation est cruciale pour prévenir des complications graves liées à l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Quand faut-il consulter un médecin ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes persistent ou s'aggravent malgré le traitement."
}
},
{
"@type": "Question",
"name": "Le repos est-il recommandé ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos est essentiel pour permettre au corps de récupérer."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des coups de chaleur, des défaillances organiques et des convulsions."
}
},
{
"@type": "Question",
"name": "L'hyperthermie peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperthermie sévère non traitée peut entraîner la mort."
}
},
{
"@type": "Question",
"name": "Quels organes sont les plus affectés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le cerveau, le cœur et les reins sont particulièrement vulnérables à l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Des séquelles peuvent-elles persister ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles neurologiques peuvent persister après une hyperthermie sévère."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications graves ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement rapide et approprié est essentiel pour éviter les complications graves."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'hyperthermie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les enfants et celles avec des maladies chroniques sont plus à risque."
}
},
{
"@type": "Question",
"name": "L'exercice augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice intense dans des environnements chauds augmente le risque d'hyperthermie."
}
},
{
"@type": "Question",
"name": "Les médicaments influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent altérer la régulation thermique et augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'humidité joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une humidité élevée augmente le risque d'hyperthermie en réduisant l'évaporation de la sueur."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids peut augmenter le risque d'hyperthermie en réduisant l'efficacité de la thermorégulation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 15/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: abdollahima@sbmu.ac.ir.
Publications dans "Hyperthermie provoquée" :
4 publications dans cette catégorie
Affiliations :
Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Hyperthermie provoquée" :
3 publications dans cette catégorie
Affiliations :
The Ohio Attorney General's Center for the Future of Forensic Science, USA. Electronic address: jesprag@bgsu.edu.
Publications dans "Hyperthermie provoquée" :
3 publications dans cette catégorie
Affiliations :
Leishmaniasis Research Center, Department of Anatomy, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Publications dans "Hyperthermie provoquée" :
3 publications dans cette catégorie
Affiliations :
Department of Anatomical Sciences & Cognitive Neuroscience, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Central South University, Changsha, China.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Central South University, Changsha, China.
Hunan Key Laboratory of Ophthalmology, Changsha, China.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
School of Basic Medical Science, Xinjiang Medical University, Urumqi, China.
Department of Forensic Science, School of Basic Medical Science, Central South University, Changsha, China.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Ohio Attorney General's Center for the Future of Forensic Science, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Department of Biological Sciences, Bowling Green State University, Bowling Green, OH, 43403, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Department of Biological Sciences, Bowling Green State University, Bowling Green, OH, 43403, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Department of Biological Sciences, Bowling Green State University, Bowling Green, Ohio, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Department of Biological Sciences, Bowling Green State University, Bowling Green, Ohio, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Jichi Medical University, Japan. Electronic address: okada-tsuyoshi@clear.ocn.ne.jp.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Jichi Medical University, Japan; Cocoro Care Center, Jichi Medical University, Japan.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Jichi Medical University, Japan.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Universidad de Castilla-La Mancha. Department of Inorganic, Organic Chemistry and Biochemistry. Faculty of Chemical and Technological Sciences. School of Medicine of Ciudad Real. Regional Centre of Biomedical Research (CRIB), Avenida Camilo José Cela, 10, 13071 Ciudad Real, Spain.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Universidad de Castilla-La Mancha. Department of Inorganic, Organic Chemistry and Biochemistry. Faculty of Chemical and Technological Sciences. School of Medicine of Ciudad Real. Regional Centre of Biomedical Research (CRIB), Avenida Camilo José Cela, 10, 13071 Ciudad Real, Spain. Electronic address: Davidagustin.leon@uclm.es.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Universidad de Castilla-La Mancha. Department of Inorganic, Organic Chemistry and Biochemistry. Faculty of Chemical and Technological Sciences. School of Medicine of Ciudad Real. Regional Centre of Biomedical Research (CRIB), Avenida Camilo José Cela, 10, 13071 Ciudad Real, Spain.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Hyperthermie provoquée" :
The gene encoding proprotein convertase subtilisin/kexin type 9 (PCSK9) and its protein product have been widely studied for their role in cholesterol and lipid metabolism. PCSK9 increases the rate of...
Although the proprotein convertase subtilisin kexin-9 inhibitors (PCSK9i) were shown to significantly lower low-density lipoprotein and reduce atherosclerotic cardiovascular disease events in clinical...
Sepsis is a life-threatening condition that arises when the body's response to infection causes injury to its tissues and organs. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an enzyme rel...
To determine the harms of proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors in people who need lipid-lowering therapy....
This systematic review included randomised controlled trials that compared PCSK9 inhibitors with placebo, standard care or active lipid-lowering comparators in people who need lipid-lowering therapy w...
We included 32 trials with 65 861 participants (with the median follow-up duration of 40 weeks, ranging from 24 to 146 weeks). The meta-analysis showed an incidence of injection-site reaction leading ...
PCSK9 inhibitors slightly increase the risk of severe injection-site reaction but not cataracts, gastrointestinal haemorrhage, neurocognitive events, new-onset diabetes or severe myalgia or muscular p...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a new target for reducing low-density lipoprotein cholesterol and incident cardiovascular disease, including stroke. However, the clinical rele...
In community-dwelling Japanese men (n = 526) aged 46-82 years without a history of cardiovascular disease, the associations of serum PCSK9 levels with the prevalence of CSVD and ICAS were assessed usi...
The median (interquartile range) age at baseline and serum PCSK9 levels were 69 (63-74) years and 240 (205-291) ng/ml, respectively. After adjusting for traditional cardiovascular risk factors includi...
Higher circulating PCSK9 levels were independently associated with an ICAS prevalence but not with CSVD prevalence. The quantification of circulating PCSK9 levels may help to identify individuals at h...
Proprotein convertase subtilisin/kexin type-9 (PCSK9) is a posttranslational regulator of the LDL receptor (LDLR). Recent studies have proposed a role for PCSK9 in regulating immune responses. Using R...
Guidelines advocate for intensive lipid-lowering in patients with atherosclerotic cardiovascular disease (ASCVD). In May 2020, evolocumab, a proprotein convertase subtilisin-kexin type 9 (PCSK9) inhib...
To identify barriers to prescribing PCSK9 inhibitors in hospitalised patients with ASCVD....
A retrospective 3-month, single-site, observational analysis was conducted in consecutive patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery. L...
Of 331 patients, 244 (73.7%) underwent PCI and 87 (26.3%) underwent CABG surgery. A lipid profile during or within 8 weeks of admission was measured for 202 (82.8%) patients undergoing PCI and 59 (67....
Prescribing of non-statin LDL-C-lowering therapies remains low in patients with ASCVD. Underprescribing of ezetimibe and suboptimal lipid testing rates are barriers to accessing subsidised PCSK9i ther...
Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) levels have been suggested as novel atherosclerotic biomarker. PCSK9 plays important roles in the pathogenesis of atherosclerosis by regulating th...
This cross-sectional analysis enrolled 401 Caucasian patients with type II diabetes mellitus (T2DM). PCSK9 levels were measured by ELISA test, arterial stiffness was estimated by measuring carotid-fem...
Patients were divided in three tertiles according to increasing value of PCSK9. From the I to the III tertiles, there was a significant increase in high sensitivity C-reactive protein (hs-CRP), fibrin...
Our study demonstrates a close association between circulating PCSK9 levels and PWV in T2DM subjects without previous CV events even after adjusting for well-known CV risk factor and pharmacological m...
Proprotein convertase subtilisin/kexin-type 9 inhibitor (PCSK9i) treatment reduces cardiovascular events when taken over a long time for secondary prevention. Data on treatment adherence are scarce an...
Baseline data and prescription patterns of all 7302 patients with PCSK9i prescriptions dispensed on the account of Austrian Social Insurances between September 2015 and December 2020 were retrieved an...
Considering the high PDC and low discontinuation rates, the majority of patients adhere to PCSK9i treatment. Hence, in a system where PCSK9i treatment is made available at virtually no costs for patie...
Proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces low density lipoprotein (LDL) uptake, leading to increased plasma levels of LDL. In addition, PCSK9 has been implicated in inflammation in...